Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025
Vanda Pharmaceuticals (Nasdaq: VNDA) has announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 13, 2025, after market close. The company will host a conference call at 4:30 PM ET on the same day to discuss the financial results and other corporate activities.
Participants can join the conference call by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) using passcode 2881765. The call will be simultaneously broadcast and archived on Vanda's website. A replay will be available from 8:30 PM ET on February 13 until February 20, 2025, at 11:59 PM ET.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha annunciato che pubblicherà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 giovedì 13 febbraio 2025, dopo la chiusura del mercato. L'azienda ospiterà una conference call alle 16:30 ET lo stesso giorno per discutere i risultati finanziari e altre attività aziendali.
I partecipanti possono unirsi alla conference call componendo il numero 1-800-715-9871 (nazionale) o 1-646-307-1963 (internazionale) utilizzando il codice di accesso 2881765. La chiamata sarà trasmessa in diretta e archiviata sul sito web di Vanda. Una registrazione sarà disponibile dalle 20:30 ET del 13 febbraio fino al 20 febbraio 2025, alle 23:59 ET.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 el jueves 13 de febrero de 2025, después del cierre del mercado. La compañía llevará a cabo una llamada de conferencia a las 4:30 PM ET el mismo día para discutir los resultados financieros y otras actividades corporativas.
Los participantes pueden unirse a la llamada de conferencia marcando el 1-800-715-9871 (nacional) o el 1-646-307-1963 (internacional) utilizando el código de acceso 2881765. La llamada se transmitirá simultáneamente y se archivará en el sitio web de Vanda. Una repetición estará disponible desde las 8:30 PM ET del 13 de febrero hasta el 20 de febrero de 2025, a las 11:59 PM ET.
반다 제약(Vanda Pharmaceuticals, Nasdaq: VNDA)은 2024년 4분기 및 전체 연도 재무 결과를 2025년 2월 13일 목요일, 시장 종료 후 발표할 것이라고 밝혔습니다. 회사는 같은 날 오후 4시 30분 ET에 컨퍼런스 콜을 열어 재무 결과 및 기타 기업 활동에 대해 논의할 예정입니다.
참가자는 1-800-715-9871 (국내) 또는 1-646-307-1963 (국제)로 전화하여 비밀번호 2881765를 입력하여 컨퍼런스 콜에 참여할 수 있습니다. 이 통화는 동시에 방송되며 반다 웹사이트에 아카이브됩니다. 재생은 2025년 2월 13일 오후 8시 30분 ET부터 2025년 2월 20일 오후 11시 59분 ET까지 제공될 예정입니다.
Vanda Pharmaceuticals (Nasdaq: VNDA) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 le jeudi 13 février 2025, après la fermeture du marché. L'entreprise organisera une conférence téléphonique à 16h30 ET le même jour pour discuter des résultats financiers et d'autres activités de l'entreprise.
Les participants peuvent rejoindre la conférence téléphonique en composant le 1-800-715-9871 (national) ou le 1-646-307-1963 (international) en utilisant le code d'accès 2881765. L'appel sera diffusé simultanément et archivé sur le site Web de Vanda. Un replay sera disponible à partir de 20h30 ET le 13 février jusqu'au 20 février 2025 à 23h59 ET.
Vanda Pharmaceuticals (Nasdaq: VNDA) hat angekündigt, dass die Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 am Donnerstag, den 13. Februar 2025, nach Börsenschluss veröffentlicht werden. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz veranstalten, um die finanziellen Ergebnisse und andere Unternehmensaktivitäten zu besprechen.
Teilnehmer können sich in die Telefonkonferenz einwählen unter 1-800-715-9871 (inländisch) oder 1-646-307-1963 (international) unter Verwendung des Zugangscodes 2881765. Der Anruf wird gleichzeitig übertragen und auf der Website von Vanda archiviert. Eine Wiederholung wird vom 13. Februar um 20:30 Uhr ET bis zum 20. Februar 2025 um 23:59 Uhr ET verfügbar sein.
- None.
- None.
Conference Call and Webcast to Follow
Vanda will host a conference call at 4:30 PM ET on Thursday, February 13, 2025, during which management will discuss the fourth quarter and full year 2024 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 2881765.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Thursday, February 13, 2025, beginning at 8:30 PM ET and will be accessible until Thursday, February 20, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 2881765.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-13-2025-302369401.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When will Vanda Pharmaceuticals (VNDA) release Q4 and full year 2024 earnings?
How can investors access VNDA's Q4 2024 earnings conference call?
What time is Vanda Pharmaceuticals' Q4 2024 earnings call?
How long will VNDA's Q4 2024 earnings call replay be available?
